Nirvana Life Sciences Inc. (CSE:NIRV)

Canada flag Canada · Delayed Price · Currency is CAD
0.1050
0.00 (0.00%)
Apr 15, 2025, 10:05 AM EDT
-47.50%
Market Cap 506.45K
Revenue (ttm) n/a
Net Income (ttm) -543.70K
Shares Out 4.82M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 500
Average Volume 462
Open 0.1050
Previous Close 0.1050
Day's Range 0.1050 - 0.1050
52-Week Range 0.0300 - 0.8000
Beta 0.85
RSI 45.21
Earnings Date Apr 3, 2025

About Nirvana Life Sciences

Nirvana Life Sciences Inc. engages in the research and development of therapeutic products to address addiction. The company is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Bruce Clark
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol NIRV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.